Экспериментальные исследования биологической активности различных соединений из морских гидробионтов
Диссертация
Одной из актуальных задач современной биохимии в области биомедицинских исследований является поиск и изучение новых эффективных препаратов, используемых при лечении различных патологий человека. Известно, что около половины всех имеющихся на настоящий момент лекарственных средств разработаны на основе соединений, выделенных из наземных источников. Однако в недрах мирового океана имеется огромное… Читать ещё >
Список литературы
- Артюков A.A., Попов A.M., Цыбульский A.B., Кривошапко О.Н, Полякова Н. В. Фармакологическая активность эхинохрома, А отдельно и в составе БАД «Тимарин» // Биомедицинская химия. 2012. Т. 59, № 3. С. 281−290.
- Билич Г. Л, Колла В. Э. Регуляция регенерации клетка, ткань, организм II Фармакологическая регуляция регенераторных процессов в эксперименте и клинике: межвузовский сборник ГГУ. Горький, 1978. С. 10−20.
- Дерягина В. П, Рыжова Н. И, Ильницкай А. П, Травкин А. Г, Трещалкина Е. М, Андронова Н. В. Действие природного антиоксиданта эхинохрома на рост подкожно перевитой аденокарциномы Эрлиха // Российский онколог, ж. 2005. № 3. С. 32 36.
- Джильберт Э.Э. Сульфирование органических соединений / Пер. с англ. под редакцией А. И. Гершеновича. М.: «Химия». 1969. 328 с.
- Заводник И. Б, Дремза И. К, Лапшина Е. А, Чещевик В. Т. / Биологические мембраны. 2011. V. 28. № 2. Р. 83−94.
- Инькова А.Н. О чем говорят анализы/ Серия «Медицина для Вас». Ростов н/Д: «Феникс», 2000. С. 96.
- Карпищенко А.И. Медицинские лабораторные технологии. СПб.:Интер-Медика, 1999. — в 2 т.
- Кривошапко О. Н, Попов A.M., Артюков A.A. Применение биоантиоксидантов при нарушениях липидного и углеводного обмена// Здоровье. Медицинская экология. Наука. 2009. № 4−5. С. 85 88.
- Лебедев A.B., Иванова М.В, Красновид Н. И, Кольцова Е. А. Кислотные свойства и взаимодействие с супероксид анион-радикалом эхинохрома, А и его структурных аналогов // Вопросы медицинской химии. 1999.Т. 2. С. 123−130.
- Лебедев A.B., Левицкая ЕЛ, Тихонова Е.В, Иванова М. В. Антиоксидантные свойства, автоокисление и мутагенная активность Эхинохрома, А в сравнении с его структурными аналогами // Биохимия. 2001. Т. 66. вып. 8. С. 885 893.
- Макарова М.Н. Биодоступность и метаболизм флавоноидов // Вопросы питания. 201 I.T. 80, № 3. С. 4−12.
- Попов A.M. Биологическая активность и механизмы действия вторичных метаболитов из наземных растений и морских беспозвоночных // Доктор, диссертация. Владивосток, 2003. -222с.
- Попов A.M., Бурцева Т. И., Семенова Н. В., Ли И.А., Козловская Э. П. Влияние бальзамов «Гербамарин"©- на функциональное состояние сердечно-сосудистой и гапатобилиарной систем // Биомедицинская химия. 2003. Т. 49, № 4. С. 394−400.
- Раны и раневая инфекция: руководство для врачей / под ред. М. И. Кузина, Б. М. Костюченок. М.: Медицина, 1990. 592 с.
- Саватеева Л. Ю., Маслова М. Г., Володарский В. Л. Дальневосточные голотурии и асцидии как ценное пищевое сырье. Владивосток: Изд-во Дальневост. ун-та. 1983. 1 84 с.
- Самохвалов В.А., Сметанина М. Д., Мусейкина Н. М., Мельников Г. В., Федотова О. В., Игнатов В. В. Влияние низкой концентрации перекиси водорода на метаболизм клеток крови // Биомедицинская химия. 2003. Т. 49, № 2. С. 122−127.
- Хасанов В.В., Рыжова Г. Л., Мальцева Е. В. Химия растительного сырья. 2004. № 3. С. 63−75
- Юдочкин А.В., Шарафетдинов Х. Х., Плотникова О. А., Стародубова А. В. Современные представления о роли питания и генетических факторов в развитии метаболического синдрома// Вопросы питания. 2011. Т. 80, № 3. С. 18−23.
- Abubakar A., Saito Т., Kitazawa Н., Kawai Y., Itoch Т. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase К digestion // J. Dairy Sci. 1998. V. 81. P. 3131−3138.
- Aherne S.A., O’Brien N.M. Dietary flavonols: Chemistry, food content, and metabolism //Nutrition. 2002. V. 18. P. 75−81.
- Alkam Т., Nitta A., Mizoguchi H., Itoh A., Nabeshima T. A natural scavenger of peroxynitrites, rosmannic acid, protects against impairment of memory induced by Abeta (25−35) // Behav Brain Res. 2007. V. 180, № 2. P. 139−145.
- Amiri F., Shaw S., Wang X., Tang J., Waller J.L., Eaton D.C., Marrero M.B. Angiotensin II activation of the JAK./STAT pathway in mesangial cells is altered by high glucose // Kidney Int. 2002. V. 61. P. 1605−1616.
- Baeuerle P.A., Baltimore D. NF-kappa B: Ten years after // Cell. 1996. V. 87. P. 1320.
- Barros M.P., Pinto E., Colepicolo P., Pedersen M. Astaxanthin and peridinin inhibit oxidative damage in (Fe2+)-loaded liposomes: scavenging oxyradicals or changing membrane permeability? // Biochem. Biophys. Res. Commun. 2001. V. 288. P. 225−232.
- Boehm T., Folkman J., Browder T., O’Reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance //Nature. 1997. V. 390. P. 404−407.
- Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., Monks T.J. Role of quinones in toxicology //Chem. Res. Toxicol. 2000. V. 3. P. 135−160.
- Borg H., Eide S.J., Anderson A., Hellerstrom C. Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic B-cells. Biochem.J. 1979. V. 182. P. 797−802.
- Boullier A., Bird D.A., Chang M.K., Dennis E.A., Friedman P., Gillotre-Taylor K., Horkko S., Palinski W., Quehenberger O., Shaw P. Scavenger receptors, oxidized LDL, and atherosclerosis //Ann. N. Y Acad. Sci. 2001. V. 947. P. 214−222.
- Brown F.R., Corato Di A., Lorenzi G.P., Blout E.R. Synthesis and structural studies of two collagen analogues: poly (L-prolyl-L-seryl-glycyl) and poly (L-prolyl-L-alanyl-glycyl) // J. Mol. Biol. 1972. V. 63. P. 85−99.
- Brownlee M. Biochemistry and molecular cell biology of diabetic complications // Nature. 2001. V. 414. P. 813−820.
- Buffinton G.D., Ollinger K., Brunmark A., Cadenas E. DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatived and glutathionyl-quinon conjugates // Biochem. J. 1989. V. 257. P. 561−571
- Calder P.C. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale// Biochimie. 2009. V. 91, № 6. P. 791−795.
- Calder P.C. Mechanisms of action of (n-3) fatty acids // J. Nutr. 2012. V. 142, № 3. P.592S-599S.
- Calder P.C. Long-chain fatty acids and inflammation // Proc. Nutr. Soc. 2012. V. 71, № 2. P. 284−289.
- Carafa V., Nebbioso A., Altucci L. Sirtuins and disease: the road ahead // Front Pharmacol. 2012. V. 3. P. 4.
- Chen T., Li L.P., Lu X.Y., Jiang H.D., Zeng S. Absorption and Excretion of Luteolin and Apigenin in Rats after Oral Administration of Chrysanthemum morifolium Extract. // J. Agric. Food Chem. 2007. V. 55. P. 273−277.
- Choi H.D., Kang H.E., Yang S.H., Lee M.G., Shin W.G. Pharmacokinetics and first-pass metabolism of astaxanthin in rats // Br J Nutr. 2010. V. 7. P. 1−7.
- Collins T., Read M. A, Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers // Faseb J. 1995. V. 9. P. 899−909.
- Cushman D.W., Cheung H.S. Spectrophotometric assay and properties of the angiotension 1-converting enzyme of rabbit lung// Biochem. Pharmacol. 1971. V. 20. P. 1637−1648.
- Davis G.E., Bayless K.J., Davis K.J., Meininger G.A. Regulation of tissue injury responses by the exposure of matricriptic sites within extracellular matrix molecules // Am. J. Pathol. 2000. V. 156. P. 1489−1498.
- Demidova-Rice T. N., Geevarghese A., Herman I. M. Bioactive peptides derived from vascular endothelial cell extracellular matrices promote microvascular morphogenesis and wound healing in vitro // Wound Repair Regen. 2011. V. 19, № 1. P. 59−70.
- Ding L., Jin D., Chen X. Luteolin enhances insulin sensitivity via activation of PPARy transcriptional activity in adipocytes // J Nutr Biochem. 2010. V. 21, № 10. P. 941−947.
- Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002. V. 82. P. 47−95.
- Duluc L, Soleti R, Clere N, Andriantsitohaina R, Simard G. Mitochondria As Potential Targets of Fiavonoids: Focus on Adipocytes and Endothelial Cells // Curr Med Chem. 2012. Epub ahead of print.
- Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes // Endocr. Rev. 2002. V. 23. P.599−622.
- Fadel 0., El Kirat K., Morandat S. Fadel 0., El Kirat K., Morandat S. The natural antioxidant rosmarinic acid spontaneously penetrates membranes to inhibit lipid peroxidation in situ. Biochim Biophys Acta, 2011. V. 1808. № 12. P. 2973−2980.
- FitzGerald R.J., Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme // Br J Nutr. 2000. V. 84. P. 33−37.
- Friedman M., and Byers, S. O. The mechanism responsible for the hypercholesterolemia induced by Triton WR-1339 // J. Expl. Med. 1997. V. 1952. P. 117−130.
- Furuno K., Akasako T., Sugihara N. The contribution of the pyrogallol moiety to the superoxide radical scavenging activity of fiavonoids // Biol Pharm Bull. 2002. V. 25. P. 19−23.
- Gao P., Zhang H., Dinavahi R., Li F., Xiang Y., Raman V., Bhujwalla Z.M., Felsher D.W., Cheng L., Pevsner J., Lee L.A., Semenza G.L., Dang C.V. HIF-dependent antitumorigenic effect of antioxidants in vivo // Cancer Cell. 2007. V. 12. № 3. P. 230−238.
- Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors // Endocrine Rev. 2008. V. 29, № 6. P. 677−696.
- Gildberg A., Arnesen J.A., Carlehog M. Utilisation of cod backbone by biochemical fractionation // Process Biochem. 2002. V. 38. P. 475−480.
- Gradolatto A., Canivenc-Lavier M.C., Basly J.P., Siess M.H., Teyssier C. Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver// Drag, Metabolism and Disposition. 2004. V. 32, № 1. P. 58−65.
- Grankvist K., Marklund S. Influence of trace metals on alloxan cytotoxicity in pancreatic islets FEBS Lett. 1979. V.105. P. 15−18.
- Griendling K.K., FitzGerald G.A. Oxidative stress and cardiovascular injury: Part 1: basic mechanisms and in vivo monitoring of ROS / Circulation. 2003. V. 108. P. 1912−1916.
- Han T., Cheng G., Liu Y., Yang H., Hu Y.T., Huang W. In vitro evaluation of tectoridin, tectorigenin and tectorigenin sodium sulfonate on antioxidant properties // Food Chem. Toxicol. 2012. V. 50, № 2. P. 409−414.
- Heikkila R.E., Winston B., Cohen G., Barden H. Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate. Biochem. Pharmac. 1976. V. 25. P. 1085−1092.
- Heuett W.J., Periwal V. Autoregulation of free radicals via uncoupling protein control in pancreatic beta-cell mitochondria// Biophys J. 2010. V. 98, № 2. P. 207−217.
- Hoshino J., Park E.J., Kondratyuk T.P., Marler L., Pezzuto J.M., van Breemen R.B., Mo S., Li Y., Cushman M. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites// J. Med. Chem. 2010. V. 53, № 13. P. 5033−5043.
- Hyun, C.K., Shin, H.K., 2000. Utilization of bovine blood plasma proteins for the production of angiotensin I converting enzyme inhibitory peptides. Process Biochem. 36, 65−71.
- Huang D., Ou B., Prior R.L. The chemistry behind antioxidant capacity assays // J. Agric. Food Chem. 2005. V. 53, № 6. P. 1841−1856.
- Huang Z., Fang F., Wang J., Wong C.-W. Structural activity relationship of flavonoids with estrogen-related receptor gamma // FEBS Letters. 2010. V. 584. P. 22−26.
- Humaloja, K., Roine, R. P., and Salaspuro, M., Effect of Triton WR-1339 and orotic acid on biliary and serum dolichols in rats // Metabolism. 1998. P. 47. P. 644−649.
- Iwamoto T., Hosoda K., Hirano R., Kurata H., Matsumoto A., Miki W., Kamiyama M., Itakura H., Yamamoto S., Kondo K. Inhibition of low-density lipoprotein oxidation by astaxanthin Hi. Atheroscler. Thromb. 2000. V. 7. P. 216−222.
- Jay M.A., Ren J. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus // Curr Diabetes Rev. 2007. V. 3, № 1. P. 33−39.
- Je J.Y., Park P.J., Byun H.G., Jung W.K., Kim S.K. Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis // Bioresour Technol. 2005. V. 96, № 14. P. 1624−1629.
- Jeong E., Lee J.Y. Intrinsic and extrinsic regulation of innate immune receptors // Yonsei Med J. 2011. V. 52, № 3. p. 379−392.
- Kalupahana NS, Claycombe KJ, Moustaid-Moussa N. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights // Adv Nutr. 2011. V. 2, № 4. P. 304−316.
- Karamouzis M.V., Moschos S.J. The use of endostatin in the treatment of solid tumors // Expert Opin. Biol. Ther. 2009. V. 9. P. 641−648.
- Kohama, Y., Matsumoto, S., Oka, H., Teramoto, T., Okabe, M., Mimura, T. Isolation of angiotensin-converting enzyme inhibitor from tuna muscle // Biochem. Biophys. Res. Commun. 1988. V. 155. P. 332−337.
- Kohumura, M., Nio, N., Kudo, K., Minoshima, Y., Munekata, E., Ariyoshi, Y. Inhibition of angiotensin-converting enzyme by synthetic peptides of human b-casein. Agric // Biol. Chem. 1989. V. 53. P. 2107−2114.
- Korhonen H., Pihlanto A. Food-derived bioactive peptides—Opportunities for designing future foods // Curr. Pharm. Des. 2003. V. 9. P. 1297−1308.
- Koulis C., de Haan J.B., Allen T.J. Novel pathways and therapies in experimental diabetic atherosclerosis // Expert Rev. Cardiovasc. Ther. 2012. V. 10, Jte 3. P. 323−335.
- Kim B.H., Yoo J., Park S.H., Jung J.K., Cho H., Chung Y. Synthesis and evaluation of antitumor activity of navel 1,4-naphthoquinone derivatives (IV) // Arch. Pharm. Res. 2006. V. 29, № 2. P. 123−130.
- Kim H. P., Son K. H., Chang H. W., Kang S. S. Anti-inflammatory plant flavonoids and cellular action mechanisms // J. Pharmacol. Sei. 2004. V. 96. P. 229−245-
- Kim S.K., Kim Y.T., Byun H.G., Nam K.S., Joo D.S., Shahidi F. Angiotensin I converting enzyme inhibitory peptides purified from bovin skin gelatin hydrolysate // J. Agric. Food Chem. 2001. V. 49. P. 2992−2997.
- Kim S.K., Ngo D.H., Vo T.S. Marine fish-derived bioactive peptides as potential antihypertensive agents // Adv Food Nutr Res. 2012. V. 65. P. 249−60.
- Kinoshita, E., Yamakoshi, J., Ikuchi, M., 1993. Purification and identification of an antiotensin I-converting enzyme inhibitor from soy sauce // Biosci. Biotechnol. Biochem. V. 57. P. 1107−1110.
- Kruger-Zeitzer E., Sullivan S.G., Stern A., Munday R. Effects of 1,4-naphthoquinone derivatives on red blood cell metabolism//J. Appl. Toxicol. 1990. V. 10. P. 129−133.
- Kurashige M., Okimasu E., Inoue M., Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin // Physiol. Chem. Phys. Med. NMR. 1990. V. 22. P. 27−38.
- Lambert A.J., Brand M.D. Reactive oxygen species production by mitochondria // Methods Mol Biol. 2009. V. 554. P. 165−181.
- Lebedev A.V., Ivanova M.V., Ruuge E.K. How do calcium ions induce free radical oxidation of hydroxy-1,4-naphthoquinone? Ca2+ stabilizes the naphthosemiquinone anion-radical of echinochrome A //Arch. Biochem. Biophys. 2003. V. 413. P. 191−198.
- Lebedev A.V., Ivanova M.V., Levitsky D.O. Echinochrome, a naturally occurring iron chelator and free radical scavenger in artificial and natural membrane systems // Life Sei. 2005. V. 76, № 8. P. 863−875.
- Lebedev AV, Ivanova MV, Levitsky DO. Iron chelators and free radical scavengers in naturally occurring polyhydroxylated 1,4-naphthoquinones // Hemoglobin. 2008. V. 32, № 1−2. P. 165−179.
- Lee J., Jung E., Kim Y., Lee J., Park J., Hong S., Hyun C. G., Park D., and Kim Y. S. Rosmarinic acid as a downstream inhibitor of IKK-beta in TNF-alpha-induced upregulation of CCL11 and CCR3 // J. Pharmacol. 2006. V. 148. P. 366−375.
- Lee D.H., Lee Y.J., Kwon K.H. Neuroprotective Effects of Astaxanthin in Oxygen-Glucose Deprivation in SH-SY5Y Cells and Global Cerebral Ischemia in Rat // J. Clin. Biochem. Nutr. 2010. V. 47, № 2. P. 121−129.
- Leopoldini M, Russo N, Toscano M. A comparative study of the antioxidant power of flavonoid catechin and its planar analogue // J Agric Food Chem. 2007. V. 55. P. 7944−7949.
- Levchenko T. S, Hartner W. C, Torchilin V.P. Liposomes for cardiovascular targeting // Ther Deliv. 2012. V. 3, № 4. P. 501−514.
- Liaset B, Julsham K, Espe M. Chemical composition and theoretical nutritional evaluation of the produced fractions from enzymic hydrolysis of salmon frames with Protamex™ // Process Biochem. 2003. V. 38. P. 1747−1159.
- Maruyama S, Mitachi H, Awaya J, Kurono M, Tomizuka N, Suzuki 14. Angiotensin 1-converting enzyme inhibitory activity of the C-terminal hexapeptide of asl-casein // Agric. Biol. Chem. 1989. V. 53. P. 2107−2114.
- McMillan D. C, Sarvate S. D, Oatis J. E, Jollow D.J. Role of oxidant stress in lawsone-induced hemolytic anemia//Toxicological Sciences. 2004. V. 82. P. 647−655.
- McNulty H.P., Byun J., Lockwood S.F., Jacob R.F., Mason R. P: Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis // Biochim. Biochys. Acta. 2007. V. 1768. P. 167−174.
- Meisel H. Food-derived bioactive proteins and peptides as potential components of nutraceuticals // Curr. Pharm. Des. 2007. V. 13. P. 873−874.
- Miller T.E., Dodd J., Ormrod D.J., Geddcs R. Anti-inflammato activity of glycogen extracted from Perna canaliculus (NZ gre lipped mussel) II Agents Actions // 1993. V. 38, №. 2. P. 139−141.
- Minn ?ran P., Hosseinpour-Niazi S., Naderi Z., Bahadoran Z., Sadeghi M., Azizi F. Association between interaction and ratio of co-3 and co-6 polyunsaturated fatty acid and the metabolic syndrome in adults //Nutrition. 2012. V. 28, № 9. P. 856−863.
- Miyoshi S., Ishikawa PL, Kaneko T., Fukui F., Tanaka H., Maruyama S. Structure and activity of angiotensinconverting enzyme inhibitors in an a-zein hydrolysate // Agric. Biol. Chem. 1997. V. 55. P. 1313−1318.
- Morand C., Manach C., Crespy V. & Re’me' sy, C. Quercetin 3-O-glucoside is better absorbed than other quercetin forms and is not present in rat plasma // Free Radic. Res. 2000. V. 33. P. 667−676.
- Morawietz LI. LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis // Dtsch Med Wochenschr. 2010. V. 135. P. 308−312.
- Minelli A, Grottelli S, Mierla A, Pinnen F, Cacciatore I, Bellezza I. Cyclo (His-Pro) exerts anti-inflammatory effects by modulating NF-kB and Nrf2 signalling // Int. J. Biochem. Cel. I Biol. 2012. V. 44, № 3. P. 525−535.
- Mueller P., Rudin D.O., Tien N.T., Wescott W.C. Reconstitution of cell membrane structure in vitro and its transformation into an excitable system //Nature. 1962. V. 194. P. 979−980.
- Mueller M., Lukas B., Novak J., Simoncini T., Genazzani A.R., Jungbauer A Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists // J. Agric. Food. Chem. 2008. V. 56, № 24. P. 1 1621−11 630.
- Mukinda J.T., Syce J.A., Fisher D., Meyer M. Effect of the Plant Matrix on the Uptake of Luteolin Derivatives-containing Artemisia afra Aqueous-extract in Caco-2 cells // Ethnopharmacol. 2010. V. 130, № 3. P. 439−449.
- Munday R., Fowke E.A., Smith B.L., Munday C.M. Comparative toxicity of alkyl-1,4-naphthoquinones in rats: relationship to free radical production in vitro // Free Radic Biol Med. 1994. V. 16, № 6. P. 725−731.
- Munday R., Smith B.L., Munday C.M. Effect of inducers of DT-diaphorase on the haemolytic activity and nephrotoxicity of 2-amino-l, 4-naphthoquinone in rats // Chem. Biol. Interact. 2005. V. 155,№ 3. P. 140−147.
- Munday R., Smith B.L., Munday C.M. Structure-activity relationships in the haemolytic activity and nephrotoxicity of derivatives of 1,2- and 1,4-naphthoquinone // J. Appl. Toxicol. 2007. V. 27, № 3. P. 262−269.
- Nakao R., Nelson O.L., Park J.S., Mathison B.D., Thompson P.A., Chew B.P. Effect of dietary astaxanthin at different stages of mammary tumor initiation in BALB/c mice // Anticancer Res. 2010. V. 30, № 6. P. 2171−2175.
- Nakata R., Takahashi S., Inoue H. Recent advances in the study on resveratro! // Biol. Pharm. Bull. 2012. V. 35, № 3. P. 273−279.134. «Neill S., Desikan R., Hancock J. Hydrogen peroxide signalling // Curr. Opin. Plant. Biol. 2002. V. 5. P. 388−395.
- Ngo S.N., Williams D.B., Head R.J. Rosemary and cancer prevention: preclinical perspectives // Crit. Rev. Food Sci Nutr. 2011. V. 51, № 10. P. 946−954.
- Ngo D.H., Vo T.S., Ngo D.N., Wijesekara I., Kim S.K. Biological activities and potential health benefits of bioactive peptides derived from marine organisms // Int. J. Biol. Macromol. 2012. V. 51, № 4. P. 378−383.
- Nicholson A.C., Han J., Febbraio M» Silversterin R.L., Hajjar D.P. Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis // Ann. N. Y. Acad. Sci. 2001. V. 947. P. 224−228.
- Nishioka Y., Oyagi A., Tsuruma K., Shimazawa M., Ishibashi T., Hara H. The antianxiety-like effect of astaxanthin extracted from Paracoccus carotinifaciens // Biofactors. 201 1. V. 37, № 1. P. 25−30.
- Oh PL, Kim D.H., Cho J.H., Kim Y.C. Hepatoprotective and free radical scavenging activities of phenolic petrosins and flavonoids isolated from Equisetum arvense // J. Ethnopharmacol. 2004. V. 95, № 2−3. P. 421−424.
- Okamoto A., Hanagata H., Kawamura Y., Yanagida F. Anti-hypertensive substances in fermented soybean, natto // Plant Foods Hum. «Nutr. 1995. V. 47. P. 39−47.
- Ollinger K., Brunmark A. Effect of hydroxyl substituent position on 1,4-naphthoquinone toxity to rat hepatocytes // J. Biol. Chem. 1991. V. 266, № 32. P. 21 496−21 503.
- Ondetti M.A., Rubin B., Cushman D.W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents // Science. 1977. V. 196, № 4288. P. 441−444.
- Park J.S., Chyun J. H., Kim Y. K., Line L. L. Chew B. P. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans // Nutrition & Metabolism. 2010. V. 7. P. 18−28.
- Palozza P., Krinsky N. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model // Arch Biochem. Biophys. 1992. V. 297. P. 291−295.
- Perez-Coll CS, Herkovits J. Lethal and teratogenic effects of naringenin evaluated by means of an amphibian embryo toxicity test (AMPHITOX) // Food Chem. Toxicol. 2004. V. 42, № 2. P. 299−306.
- Perry G., Epel D. Ca2±stimulated production of H202 from naphtoquinone oxidation in Arbacia eggs // Exp. Cell Res. 1981. V. 134. P. 65−72.149
- Petersen M., Simmonds M.S. J. Rosmarinic acid // Phytochemistry. 2003. V. 62, № 2. C. 121−125.
- Pihlanto-Leppala A, Koskinen P, Piilola K, Tupasela T, Korhonen H. Angiotensin 1-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides // J. Dairy Res. 2000. V. 67, № 1. P. 53−64.
- Prange A., Boddeker H., Michaelis W., Frezenius Z. Multi-element determination of trace elements in whole blood and blood serum by TXRF// Anal. Chern. 1989. V. 335. P. 914−918.
- Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease // Diabetes. 1998. V. 37. P. 1595−1607.
- Rigas B., Sun Y. Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer // Brit. J. Cancer .2008. V. 98. P. 1157 1160.
- Rutherfurd-Markwick, K.J.- Moughan, P.J. Bioactive peptides derived from food // J. AOAC Int. 2005. V. 88. P. 955−966.
- Sangeetha R.K., Baskaran V. Retinol-deficient rats can convert a pharmacological dose of astaxanthin to retinol: antioxidant potential of astaxanthin, lutein, and (3-carotene // Can J. Physiol Pharmacol. 2010. V. 88, № 10. P. 977−985.
- Santner S.J., Feil P.D., Santen R.J. In situ estrogen production via estrone sulphatase pathway in breast tumours: relative importance versus aromatase pathway // J. Clin Endocrinol. Metab. 1984. V. 59. P. 29−33.
- Sarkar D., Fisher P.B. Molecular mechanisms of aging-associated inflammation // Cancer Lett. 2006. V. 236, № 1. P. 13−23.
- Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T. Miwa S., Katsura Y., Kita T, Masaki T. An endothelial receptor for oxidized low-density lipoprotein //Nature. 1997. V. 386. P. 73−77.
- Seelinger G, Merfort I, Schempp CM. Anti-oxidant, anti-inflammatory and antiallergic activities of luteolin //Planta Med. 2008. V. 74. P. 1667−1677.
- Semenza G.L. Life with oxygen // Science. 2007. V. 318. P. 62−64.
- Shneyvays V., Leshem D., Shmist Y, Zinman T., Shainberg A. // J. Mol. Cell Cardiol. 2005. V. 39, № 1. P. 149−58.
- Soriano F.G., Virag L., Szabo C. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly (ADP-ribose) polymerase activation // J. Mol. Med. 2001. V. 79. P. 437−448.
- Spiller G.A., Dewell A. Safety of an astaxanthin-rich Haematococcus piuvialis algal extract: a randomized clinical trial // J. Med. Food. 2003. V. 6. P. 51−56.
- Spiller G.A., Dewell A. Safety of an astaxanthin-rich Haematococcus piuvialis algal extract: a randomized clinical trial // J. Med. Food. 2003. V. 6. P. 51−56.
- Sroka Z., Fecka I., Cisowski W. Antiradical and anti-H202 properties of polyphenolic compounds from an aqueous peppermint extract // Z. Naturforsch. C. 2005. V. 60, № 1 1−12. P. 826−832.
- Suh, H.J., Whang, J.H. A peptide from corn gluten hydrolysate that is inhibitory toward angiotensin I converting enzyme // Biotechnol. Lett. 1999. V. 21. P. 1055−1058.
- Sun D. Huang J, Zhang Z, Gao H, Li J, Shen M, Cao F, Wang H. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats // PLoS One. 2012. V. 7, № 3. P. 33 491.
- Suresh Y., Das U.N. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus // Prostaglandins Leulcot Essent Fatty Acids. 2006. V. 74, № 3. P. 199−213.
- Szatrowski T., Nathan C. Production of large amounts of hydrogen peroxide by humor tumor cells // Cancer Research. 1991. V. 51. P. 794−798.
- Taniyama Y., Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms// Hypertension. 2003. V. 42. P. 1075−1081.
- Testino G., Ancarani O., Sumberaz A. Omega-3 fatty acids and astaxanthin in health and disease. Recent knowledges // Recenti. Prog. Med. 2010. V. 101, № 4. P. 145−156.
- Torissen O.J., Hardy R.W., Shearer K. Pigmentation of salmonids carotenoid deposition and metabolism // CRC Critical reviews in Aquatic Sciences. 1989. V. 1. P. 209−225.
- Turko I.V., Marcondes S, Murad F. Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA: 3-oxoacid CoA-transferase // J. Physiol. Heart Circ. Physiol. 2001. V. 281. P. 2289−2294.
- Turujman S.A., Warner W.G., Wei R.R., Albert R.H. Rapid liquid chromatographic method to distinguish wild salmon from aquacultured salmon fed synthetic astaxanthin // J. AOAC. Int. 1997. V. 80. P. 622−632.
- Ueda H., Yamazaki C., Yamazaki M. Luteolin as an anti-inflammatory and antiallergic constituent of Perilla frutescens // Biol. Pharm. Bull. 2002. V. 25, № 9. P. 1197−1202.
- Ukeda, H., Matsuda, H., Osajima, K., Matsufuji, H., Matsui, T., Osajima, Y., Peptides from peptic hydrolyzate of heated sardine meat that inhibit angiotensin I-converting enzyme // Nippon Nogeikagaku Kaishii. 1992. V. 66. P. 25−29.
- Veal E.A., Day A.M., Morgan B.A. Hydrogen peroxide sensing and signaling // Mol. Cell. 2007. V. 26, № 1. P. 1−14.
- Verma R.P. Anti-cancer activities of 1,4-naphthoquinones: a QSAR study // Anticancer Agents Med Chem. 2006. V. 6, № 5. P. 489.
- Walczak R., Tontonoz P. PPARadigms and PPARadoxes: expanding roles for PPARg in the control of lipid metabolism //J. Lipid. Research. 2002. V. 43. P. 177−186.
- Wang L., Bao Y., Yang Y., Wu Y., Chen X., Si S., Hong B. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay // J. Biomol. Screen. 2010. V. 15,№ 3. P. 239−250.
- Warkentin T.E. Bivalent direct thrombin inhibitors: hirudin and bivalirudin // Best Pract. Res. Clin. Haematol. 2004. V. 17. P. 105−125.
- Watanabe H. Contact hypersensitivity: The mechanism of immune responses and T cell balance./ Linger M., Tuvel B., Wang B., Sauder D. N. // J. Interferon. Cytokine Res. 2002. V. 22. P.407−412.
- Weathington N.M., van Houwelingen A.H., Noerager B.D., Jackson P.L., Kraneveld
- A.D, Galin F.S., Folkerts G., Nijkamp F.P., Blalock J.E. A novel peptide CXCR ligand derived fromextracellular matrix degradation during airway inflammation //Nat. Med. 2006. V. 12, № 3. P. 317→ o JZJ>.
- Wisniewska A., Subczynski W.K. Effects of polar carotenoids on the shape of the hydrophobic barrier of phospholipids bilayers // Biochim. Biophys. Acta. 1998. V. 1368. P. 235−246.
- Wittig J., Herderich M., Graefe E. U. & Veit, M. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry//J. Chromatogr. B. 2001. V. 753. P. 237−243.
- Wong W. T, Ng C.H., Tsang S.Y., Huang Y, Chen Z.Y. Relative contribution of individual oxidized components in ox-LDL to inhibition on endothelium-dependent relaxation in rat aorta//Nutr Metab Cardiovasc Dis. 2011. V. 21. P. 157−164.
- Yanai H., Tomono Y., Ito K., Furutani N., Yoshida H., Tada N. Diacylglycerol oil for the metabolic syndrome // Nutr J. 2007. V. 6. P. 43−57.
- Yang R., Wang J., Liu Z., Pei X., Han X., Li Y. Antioxidant Effect of a Marine Oligopeptide Preparation from Chum Salmon (Oncorhynchus keta) by Enzymatic Hydrolysis in Radiation Injured Mice//Mar. Drugs. 2011. V. 9. P. 2304−2315.
- Yano, S., Suzuki, K., Funatsu, G. Isolation from a-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity // Biosci. Biotechnol. Biochem. 1996. V. 60. P. 661−663.
- Yoshizumi M., Abe J., Haendeler J., Huang Q. Berk B.C. Src and Cas mediate JNK activation but not ERK½ and p38 kinases by reactive oxygen species // J. Biol. Chem. 2000. V. 275. P. 1 1706−1 1712.b
- Zhang Z, Zhao M, Wang J, Ding Y, Dai X, Li Y. Oral administration of skin gelatin isolated from chum salmon (Oncorhynchus keta) enhances wound healing in diabetic rats //J. Sci. Food Agric. 2011. V. 91, № 12. P.2173−2179.